摘要
目的:研究辛伐他汀对治疗并发高脂血症的颈动脉粥样硬化斑块的影响,以及合用格列吡嗪对辛伐他汀的增效作用。方法:将高脂血症并发颈动脉粥样硬化患者108例,随机分为2组,辛伐他汀治疗组和格列吡嗪合并辛伐他汀治疗组,6个月治疗后,测量血脂生化指标、炎症因子活性和高频率彩色多普勒超声内-中膜厚度(IMT)。结果:两个治疗组,治疗后与治疗前相比,血脂指标,炎症因子指标及其IMT值都具有显著性差异(P<0.05)。与辛伐他汀单独治疗相比,格列吡嗪合并辛伐他汀治疗组的TC、TG和HDL-C没有显著性差异(P>0.05),但LDL-C显著减少(P<0.05),两组间ET-1和TNF-α以及IMT值差异显著(P<0.05)。结论:辛伐他汀能够改善血脂水平,降低炎症因子活性,进而对颈动脉粥硬化具有治疗作用,而合并格列吡嗪治疗能够起到增效作用。
To evaluate the therapeutic efficacy of simvastatin in patients with carotid atherosclerotic plaques complicated with hyperlipidemia,and the synergistic effect of glipizide. Methods: All the 108 patients were divided into two groups: group treatment with simvastatin and group treatment with simvastatin and glipizide. After treatment for 6 months, we measured the biochemical indicator of blood fat, included TC,TG,LDL-C and HDL-C ,the activity of inflammatory factors, included ET-1 and TNF-α , and the intima-media thickness (IMT). Results: Both of the 2 groups, the scores of biochemical indicator of blood lipids, activity of inflammatory factors and intima-media thickness (IMT) were changed significantly after treatment (P〈0.05). Compared with group treatment with simvastatin, the changes of the scores of TC,TG and HDL-C were not significant (P〉0.05). However, the scores of LDL-C, activity of inflammatory factors and IMT were decreased significantly (P〈0.05). Conclusion: Simvastatin could improve carotid atherosclerosis, through improving the level of blood lipids and reducing the activity of inflammatory factors, and glipizide had a synergistic effect.
出处
《现代生物医学进展》
CAS
2011年第10期1907-1909,共3页
Progress in Modern Biomedicine
关键词
格列吡嗪
辛伐他汀
血脂
炎症因子
内膜一中膜厚度
动脉粥样硬化
Glipizide
Simvastatin
Blood lipids
Inflammatory factors
Intima-media thickness(IMT)
Atherosclerosis